Cargando…

Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells

High-grade osteosarcoma occurs predominantly in adolescents and young adults and has an overall survival rate of about 60%, despite chemotherapy and surgery. Therefore, novel treatment modalities are needed to prevent or treat recurrent disease. Natural killer (NK) cells are lymphocytes with cytotox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buddingh, Emilie P., Schilham, Marco W., Ruslan, S. Eriaty N., Berghuis, Dagmar, Szuhai, Karoly, Suurmond, Jolien, Taminiau, Antonie H. M., Gelderblom, Hans, Egeler, R. Maarten, Serra, Massimo, Hogendoorn, Pancras C. W., Lankester, Arjan C.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061210/ https://www.ncbi.nlm.nih.gov/pubmed/21240486 http://dx.doi.org/10.1007/s00262-010-0965-3

Ejemplares similares

Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients
por: Buddingh, Emilie P., et al.
Publicado: (2012)

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
por: Buddingh, Emilie P, et al.
Publicado: (2015)

Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis
por: Berghuis, Dagmar, et al.
Publicado: (2012)

Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
por: Sand, Laurens G. L., et al.
Publicado: (2016)

A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes
por: Romeo, Salvatore, et al.
Publicado: (2009)

The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
por: Berghuis, Dagmar, et al.
Publicado: (2012)

Genome-wide analysis of Ollier disease: Is it all in the genes?
por: Pansuriya, Twinkal C, et al.
Publicado: (2011)

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015)

Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH
por: Cliteur, Vincent PM, et al.
Publicado: (2012)

Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma
por: Venneker, Sanne, et al.
Publicado: (2019)

Expression of the immune regulation antigen CD70 in osteosarcoma
por: Pahl, Jens HW, et al.
Publicado: (2015)

Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management
por: Hameetman, Liesbeth, et al.
Publicado: (2004)

Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours
por: Verdegaal, Suzan HM, et al.
Publicado: (2012)

Modeling Long-Term Erythropoietic Recovery After Allogeneic Stem Cell Transplants in Pediatric Patients
por: von Asmuth, Erik G. J., et al.
Publicado: (2020)

Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families
por: Jennes, Ivy, et al.
Publicado: (2011)

Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples
por: de Jong, Danielle, et al.
Publicado: (2011)

Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature
por: Mremi, Alex, et al.
Publicado: (2021)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010)

The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
por: Hens, Jef, et al.
Publicado: (2016)

Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway
por: Nord, Karolin H., et al.
Publicado: (2013)

A short-term in vivo model for giant cell tumor of bone
por: Balke, Maurice, et al.
Publicado: (2011)

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
por: McTiernan, Anne, et al.
Publicado: (2012)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2021)

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
por: Sand, Laurens G. L., et al.
Publicado: (2017)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
por: van der Maas, Nicolaas G., et al.
Publicado: (2019)

Immunotherapy: Is it different for sarcomas?
por: Cleton-Jansen, Anne-Marie, et al.
Publicado: (2012)

Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell Histiocytosis
por: Annels, Nicola E., et al.
Publicado: (2003)

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
por: Couto, Samuel C. F., et al.
Publicado: (2023)

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches
por: van der Wal, Steffen, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic “Stromal” Cells from Giant Cell Tumors of Bone
por: Venneker, Sanne, et al.
Publicado: (2022)

Single-cell transcriptomics in bone marrow delineates CD56(dim)GranzymeK(+) subset as intermediate stage in NK cell differentiation
por: Melsen, Janine E., et al.
Publicado: (2022)

Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis
por: da Costa, Cristiana E.T., et al.
Publicado: (2005)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
por: Yano, Max, et al.
Publicado: (2022)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
por: Melsen, Janine E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k94te8savj05v0asum0milg9j8